2,4-Diaminopyrimidine structure
|
Common Name | 2,4-Diaminopyrimidine | ||
|---|---|---|---|---|
| CAS Number | 156-81-0 | Molecular Weight | 110.117 | |
| Density | 1.4±0.1 g/cm3 | Boiling Point | 401.7±37.0 °C at 760 mmHg | |
| Molecular Formula | C4H6N4 | Melting Point | 143-147 °C(lit.) | |
| MSDS | Chinese USA | Flash Point | 225.6±13.7 °C | |
| Symbol |
GHS07 |
Signal Word | Warning | |
| Name | 2,4-Diaminopyrimidine |
|---|---|
| Synonym | More Synonyms |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Boiling Point | 401.7±37.0 °C at 760 mmHg |
| Melting Point | 143-147 °C(lit.) |
| Molecular Formula | C4H6N4 |
| Molecular Weight | 110.117 |
| Flash Point | 225.6±13.7 °C |
| Exact Mass | 110.059242 |
| PSA | 77.82000 |
| LogP | -0.64 |
| Vapour Pressure | 0.0±0.9 mmHg at 25°C |
| Index of Refraction | 1.695 |
| Storage condition | Refrigerator (+4°C) |
| Water Solubility | 840 g/L (25 ºC) |
| Symbol |
GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H315-H319-H335 |
| Precautionary Statements | P261-P305 + P351 + P338 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
| Hazard Codes | Xi:Irritant; |
| Risk Phrases | R36/37/38 |
| Safety Phrases | S26-S37/39 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
| HS Code | 2942000000 |
| Precursor 8 | |
|---|---|
| DownStream 5 | |
| HS Code | 2933599090 |
|---|---|
| Summary | 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|
Contribution of nitric oxide-dependent guanylate cyclase and reactive oxygen species signaling pathways to desensitization of μ-opioid receptors in the rat locus coeruleus.
Neuropharmacology 99 , 422-31, (2015) Nitric oxide (NO) is involved in desensitization of μ-opioid receptors (MOR). We used extracellular recordings in vitro to unmask the NO-dependent pathways involved in MOR desensitization in the rat l... |
|
|
Design and optimization of hybrid of 2,4-diaminopyrimidine and arylthiazole scaffold as anticancer cell proliferation and migration agents.
Eur. J. Med. Chem. 96 , 269-80, (2015) Therapeutics of metastatic or triple-negative breast cancer are still challenging in clinical. Herein we demonstrated the design and optimization of a series of hybrid of 2,4-diaminopyrimidine and ary... |
|
|
Cocrystals of 6-methyl-2-thiouracil: presence of the acceptor-donor-acceptor/donor-acceptor-donor synthon.
Acta Crystallogr. C Struct. Chem. 71(Pt 3) , 229-38, (2015) The results of seven cocrystallization experiments of the antithyroid drug 6-methyl-2-thiouracil (MTU), C(5)H(6)N(2)OS, with 2,4-diaminopyrimidine, 2,4,6-triaminopyrimidine and 6-amino-3H-isocytosine ... |
| 2,4(1H,3H)-Pyrimidinediimine |
| 2,4-Pyrimidinediamine |
| MFCD00038023 |
| 2,3-DIPHENYL-6-NITROQUINOXALINE |
| 2,4-diamino-pyrimidine |
| pyrimidinediamine |
| 2,6-diaminopyrimidine |
| 2,4-Diaminopyrimidine |
| Pyrimidine,2,4-diamino |
| diamino-pyrimidine |
| DAP |
| diaminopyrimidine |
| 2,4-diaminopyridine |
| Pyrimidine-2,4-diamine |
| pyrimidine-2,4-diyldiamine |
| EINECS 205-862-3 |